Combination Use of Tegafur and Apatinib as First-Line Therapy in Treatment of Advanced Gastric Cancer: A Single-Blinded Randomized Study

OBJECTIVE: To investigate the efficacy and safety of the combination use of tegafur and apatinib as a first-line therapy strategy in advanced gastric cancer (GC). METHODS: The present study included a total of 62 advanced GC patients. The patients were randomized into the combined group (treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chaofeng, Tang, Tao, Wang, Wenyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165347/
https://www.ncbi.nlm.nih.gov/pubmed/32328095
http://dx.doi.org/10.1155/2020/3232950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165347/
https://www.ncbi.nlm.nih.gov/pubmed/32328095
http://dx.doi.org/10.1155/2020/3232950

Ejemplares similares